Jun 15, 2020
Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020
Jun 01, 2020
CeloNova Announces Enrollment Completion of World's First Randomized Control, 14-Day DAPT Trial
Mar 28, 2020
Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
Jan 29, 2020
CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Dec 17, 2019
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
Dec 12, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Sep 26, 2019
Coronary Stent Patients May Not Need Long-Term Aspirin - Mount Sinai
Sep 26, 2019
Boston Scientific Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY(TM) Bioabsorbable Polymer Stent
Aug 06, 2019
CeloNova Announces Appointment of New President and CEO
Apr 09, 2019
Genus Lifesciences, Inc. Relaunches Yosprala® for Secondary CVD Prevention at $33 A Month
Mar 17, 2019
Bayer statement on new 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease
Mar 06, 2019
Late-Breaking Data Presentations at ACC 2019 Highlight Abbott's Leading Cardiovascular Portfolio
Jan 30, 2019
Researchers Find Antidepressants Significantly Increase Risk of Gastrointestinal, Intracranial Bleeding
May 29, 2018
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray
Jan 23, 2018
Egalet's Partner OraPharma Begins Promotion of SPRIX® Nasal Spray
Jan 03, 2018
Egalet Partners with OraPharma to Co-Promote SPRIX® Nasal Spray
Sep 18, 2017
National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management
Sep 05, 2017
Egalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray
Jun 07, 2017
Aralez Announces National U.S. Commercial Launch Of Zontivity
Jun 07, 2017
Egalet Partners with Ascend Therapeutics® U.S., LLC to Co-Promote SPRIX® Nasal Spray